Unknown NA INTERVENTIONAL 2-arm NCT03762005

Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock

Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock: ANDROMEDA-SHOCK PHYSIOLOGY STUDY

Sponsor: Comisión Nacional de Investigación Científica y Tecnológica

Conditions Hyperlactatemia Peripheral Perfusion Septic Shock

Interventions CRT guided resuscitation Lactate guided resuscitation

Updated 5 times since 2019 Last updated: Nov 29, 2018 Started: Jun 1, 2018 Primary completion: Sep 30, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03762005, this NA trial focuses on Hyperlactatemia and Peripheral Perfusion and remains ongoing. Sponsored by Comisión Nacional de Investigación Científica y Tecnológica, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Dec 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2019 — Dec 2020 [monthly]

Recruiting NA

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Comisión Nacional de Investigación Científica y Tecnológica
Pontificia Universidad Catolica de Chile

Data source: Pontificia Universidad Catolica de Chile

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santiago, Chile